# A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

> **NCT07443059** · PHASE1 · RECRUITING · sponsor: **Beijing QL Biopharmaceutical Co.,Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Overweight , Obesity

## Interventions

- **DRUG:** Zovaglutide
- **DRUG:** Zovaglutide
- **DRUG:** Zovaglutide
- **DRUG:** Zovaglutide

## Key facts

- **NCT ID:** NCT07443059
- **Lead sponsor:** Beijing QL Biopharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2026-12-03
- **Final completion:** 2027-03-19
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07443059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07443059, "A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07443059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*